Camilia (Laboratoires Boiron)
Welcome to the PulseAid listing for the Camilia drug offered from Laboratoires Boiron. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Laboratoires Boiron |
NON-PROPRIETARY NAME: | MATRICARIA RECUTITA, RHUBARB, PHYTOLACCA AMERICANA ROOT |
SUBSTANCE NAME: | MATRICARIA RECUTITA; RHUBARB; PHYTOLACCA AMERICANA ROOT |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | LIQUID |
MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
START MARKETING DATE: | 2010-12-01 |
END MARKETING DATE: | 0000-00-00 |
Camilia HUMAN OTC DRUG Details:
Item Description | Camilia from Laboratoires Boiron |
LABELER NAME: | Laboratoires Boiron |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 9; 5; 5([hp_C]/1; [hp_C]/1; [hp_C]/1) |
START MARKETING DATE: | 2010-12-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0220-9054_58a2c5cf-0702-4ba3-825f-d1d9f7e5bc60 |
PRODUCT NDC: | 0220-9054 |
APPLICATION NUMBER: | |
Other MATRICARIA RECUTITA; RHUBARB; PHYTOLACCA AMERICANA ROOT Pharmaceutical Manufacturers / Labelers: